These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 7628164

  • 1. Bone mineral content in nephrotic children on long-term, alternate-day prednisone therapy.
    Polito C, La Manna A, Todisco N, Cimmaruta E, Sessa G, Pirozzi M.
    Clin Pediatr (Phila); 1995 May; 34(5):234-6. PubMed ID: 7628164
    [Abstract] [Full Text] [Related]

  • 2. Long-term, high-dose glucocorticoids and bone mineral content in childhood glucocorticoid-sensitive nephrotic syndrome.
    Leonard MB, Feldman HI, Shults J, Zemel BS, Foster BJ, Stallings VA.
    N Engl J Med; 2004 Aug 26; 351(9):868-75. PubMed ID: 15329424
    [Abstract] [Full Text] [Related]

  • 3. The effect of vitamin D and calcium supplementation in pediatric steroid-sensitive nephrotic syndrome.
    Banerjee S, Basu S, Sen A, Sengupta J.
    Pediatr Nephrol; 2017 Nov 26; 32(11):2063-2070. PubMed ID: 28725977
    [Abstract] [Full Text] [Related]

  • 4. Glucocorticoid-induced osteoporosis in the lumbar spine, forearm, and mandible of nephrotic patients: a double-blind study on the high-dose, long-term effects of prednisone versus deflazacort.
    Olgaard K, Storm T, van Wowern N, Daugaard H, Egfjord M, Lewin E, Brandi L.
    Calcif Tissue Int; 1992 Jun 26; 50(6):490-7. PubMed ID: 1525702
    [Abstract] [Full Text] [Related]

  • 5. Effect of glucocorticoids on growth and bone mineral density in children with nephrotic syndrome.
    Ribeiro D, Zawadynski S, Pittet LF, Chevalley T, Girardin E, Parvex P.
    Eur J Pediatr; 2015 Jul 26; 174(7):911-7. PubMed ID: 25573461
    [Abstract] [Full Text] [Related]

  • 6. Effect of two prophylactic bolus vitamin D dosing regimens (1000 IU/day vs. 400 IU/day) on bone mineral content in new-onset and infrequently-relapsing nephrotic syndrome: a randomised clinical trial.
    Muske S, Krishnamurthy S, Kamalanathan SK, Rajappa M, Harichandrakumar KT, Sivamurukan P.
    Paediatr Int Child Health; 2018 Feb 26; 38(1):23-33. PubMed ID: 28466679
    [Abstract] [Full Text] [Related]

  • 7. Effect of prednisone on growth and bone mineral content in childhood glomerular disease.
    Chesney RW, Mazess RB, Rose P, Jax DK.
    Am J Dis Child; 1978 Aug 26; 132(8):768-72. PubMed ID: 685891
    [Abstract] [Full Text] [Related]

  • 8. Markers of bone metabolism in children with nephrotic syndrome treated with corticosteroids.
    Pańczyk-Tomaszewska M, Adamczuk D, Kisiel A, Skrzypczyk P, Przedlacki J, Górska E, Stelmaszczyk-Emmel A, Demkow U, Roszkowska-Blaim M.
    Adv Exp Med Biol; 2015 Aug 26; 840():21-8. PubMed ID: 25310960
    [Abstract] [Full Text] [Related]

  • 9. Calcium and vitamin D for osteoprotection in children with new-onset nephrotic syndrome treated with steroids: a prospective, randomized, controlled, interventional study.
    Choudhary S, Agarwal I, Seshadri MS.
    Pediatr Nephrol; 2014 Jun 26; 29(6):1025-32. PubMed ID: 24414607
    [Abstract] [Full Text] [Related]

  • 10. Alternate-day versus intermittent prednisone in frequently relapsing nephrotic syndrome. A report of "Arbetsgemeinschaft für Pädiatrische Nephrologie".
    Lancet; 1979 Feb 24; 1(8113):401-3. PubMed ID: 84259
    [Abstract] [Full Text] [Related]

  • 11. [Dynamics of bone biochemical markers in nephrotic children treated with prednisone and metabolites of vitamin D].
    Wojnar J, Roszkowska-Blaim M, Pańczyk-Tomaszewska M.
    Przegl Lek; 2007 Feb 24; 64(9):552-8. PubMed ID: 18510075
    [Abstract] [Full Text] [Related]

  • 12. Are children with idiopathic nephrotic syndrome at risk for metabolic bone disease?
    Gulati S, Godbole M, Singh U, Gulati K, Srivastava A.
    Am J Kidney Dis; 2003 Jun 24; 41(6):1163-9. PubMed ID: 12776267
    [Abstract] [Full Text] [Related]

  • 13. Alternate-day steroids affect carpal maturation more than radius, ulna and short bones.
    Polito C, Greco N, Opallo A, Cimmaruta E, La Manna A.
    Pediatr Nephrol; 1994 Aug 24; 8(4):480-2. PubMed ID: 7947042
    [Abstract] [Full Text] [Related]

  • 14. Bone mineral content and mineral metabolism during cyclosporine treatment of nephrotic Syndrome.
    Freundlich M.
    J Pediatr; 2006 Sep 24; 149(3):383-9. PubMed ID: 16939753
    [Abstract] [Full Text] [Related]

  • 15. Comparison of different regimens of prednisone therapy in frequently relapsing nephrotic syndrome.
    Wingen AM, Müller-Wiefel DE, Schärer K.
    Acta Paediatr Scand; 1990 Mar 24; 79(3):305-10. PubMed ID: 2333744
    [Abstract] [Full Text] [Related]

  • 16. Longitudinal follow-up of bone mineral density in children with nephrotic syndrome and the role of calcium and vitamin D supplements.
    Gulati S, Sharma RK, Gulati K, Singh U, Srivastava A.
    Nephrol Dial Transplant; 2005 Aug 24; 20(8):1598-603. PubMed ID: 15956073
    [Abstract] [Full Text] [Related]

  • 17. Serum 25 (OH) D and 24,25 (OH)2 levels in childhood nephrosis under different therapeutic regimens of steroid administration.
    Kano K, Suda T.
    Eur J Pediatr; 1982 Mar 24; 138(2):162-5. PubMed ID: 7094938
    [Abstract] [Full Text] [Related]

  • 18. Short versus standard prednisone therapy for initial treatment of idiopathic nephrotic syndrome in children. Arbeitsgemeinschaft für Pädiatrische Nephrologie.
    Lancet; 1988 Feb 20; 1(8582):380-3. PubMed ID: 2893190
    [Abstract] [Full Text] [Related]

  • 19. Bone mineral density in children with steroid-sensitive nephrotic syndrome.
    Mishra OP, Meena SK, Singh SK, Prasad R, Mishra RN.
    Indian J Pediatr; 2009 Dec 20; 76(12):1237-9. PubMed ID: 19936659
    [Abstract] [Full Text] [Related]

  • 20. Delayed pubertal growth spurt in glomerulopathic boys receiving alternate-day prednisone.
    Polito C, Di Toro R.
    Child Nephrol Urol; 1992 Dec 20; 12(4):202-7. PubMed ID: 1473093
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.